Jamjoom Pharmaceuticals Factory Co. (4015)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Major Shareholders
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

{{ 'components.chart.period.' + period | translate }}

{{ 'components.chart.type.' + type | translate }}

This mark means that there are news on this date.

Stock

Par Value 10.0 Saudi Riyal

Market Cap 10,920,000,000.00 Saudi Riyal

Book Value (BVPS) 24.03 Saudi Riyal Based on: Second Quarter 2025

P/B Ratio 7.84 Last update: 2025-08-16

EPS 7.54 Saudi Riyal Based on: Second Quarter 2025

P/E Ratio 19.30 Last update: 2025-08-16

Trading Currency Saudi Riyal

Company Statistics

News

Jamjoom Pharma pens MoU to boost healthcare services in Saudi Arabia Company News

Jamjoom Pharma logs 7% higher net profits in Q1-26 Financial Results

Jamjoom Pharma’s profits surge 30% in 2025; dividends for H2 unveiled Board of Directors

Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem Companies Investments

Jamjoom Pharma’s net profits near SAR 396m in 9M-25 Financial Results

Jamjoom Pharma launches new brand identity to accelerate regional growth Companies Investments

Market Announcements